ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

NBIX Neurocrine Biosciences Inc

134.97
1.90 (1.43%)
2024年6月8日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Neurocrine Biosciences Inc NBIX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
1.90 1.43% 134.97 09:00:00
始値 安値 高値 終値 前日終値
133.49 132.28 136.25 134.97 133.07
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/6/0505:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/0321:01PRNUSNeurocrine Biosciences Presented CAHtalyst™ Phase 3..
2024/6/0320:35PRNUSNeurocrine Biosciences Announces Publication of Primary..
2024/6/0320:30PRNUSNeurocrine Biosciences Announces Publication of Primary..
2024/5/3105:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/3005:53EDGAR2Form 144 - Report of proposed sale of securities
2024/5/3005:01PRNUSNeurocrine Biosciences to Participate at Investor..
2024/5/2905:14PRNUSNeurocrine Biosciences Announces CEO Succession Plan
2024/5/2821:30PRNUSNeurocrine Biosciences to Present New Phase 3 CAHtalyst™..
2024/5/2407:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2407:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2407:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2407:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2407:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2407:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2407:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2407:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2406:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2405:01EDGAR2Form 8-K - Current report
2024/5/2206:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2206:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2206:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2206:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2205:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2205:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2205:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2205:05PRNUSNeurocrine Biosciences Announces Publication of Phase 3..
2024/5/1805:32EDGAR2Form 144 - Report of proposed sale of securities
2024/5/1805:31EDGAR2Form 144 - Report of proposed sale of securities
2024/5/1805:31EDGAR2Form 144 - Report of proposed sale of securities
2024/5/1705:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1705:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1505:23EDGAR2Form 144 - Report of proposed sale of securities
2024/5/1505:23EDGAR2Form 144 - Report of proposed sale of securities
2024/5/1421:30PRNUSNeurocrine Biosciences Presented Baseline Data from the..
2024/5/0922:45PRNUSNeurocrine Biosciences Presents CAHtalyst™ Adult Study..
2024/5/0921:30PRNUSNeurocrine Biosciences Announces Initiation of Phase 1..
2024/5/0905:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/0821:30PRNUSNeurocrine Biosciences Announces Initiation of Phase 1..
2024/5/0805:15PRNUSNeurocrine Biosciences to Present at the BofA Securities..
2024/5/0721:30PRNUSNeurocrine Biosciences to Present Phase 3 Baseline..
2024/5/0621:30PRNUSNeurocrine Biosciences Supports Tardive Dyskinesia Awareness..
2024/5/0402:15PRNUSNeurocrine Biosciences Presented CAHtalyst™ Pediatric Study..
2024/5/0120:00PRNUSNeurocrine Biosciences Reports First Quarter 2024 Financial..
2024/5/0106:12PRNUSNeurocrine Biosciences Announces U.S. FDA Approval of..
2024/4/2421:30PRNUSNeurocrine Biosciences Launches WHAT THE C@H?! Educational..
2024/4/2320:00PRNUSNeurocrine Biosciences Reports Positive Phase 2 Data for..
2024/4/1705:01GLOBESentia Medical Sciences and Neurocrine Biosciences Extend..
2024/4/1105:01PRNUSNeurocrine Biosciences Announces Conference Call and Webcast..
2024/4/0321:30PRNUSNeurocrine Biosciences Announces First-Patient Dosed in..

最近閲覧した銘柄

Delayed Upgrade Clock